International Edition
Latest News
Health

Capillary Blood Sampling for Alzheimer’s Biomarker Detection

New Blood Test Shows Promise for Early Alzheimer's DetectionTable of ContentsNew Blood Test Shows Promise for Early Alzheimer's DetectionHow the Test WorksWhy Early Detection MattersBenefits of a Dried Blood Spot TestWhat This Means for the FutureSource A new…

Capillary Blood Sampling for Alzheimer’s Biomarker Detection

New Blood Test Shows Promise for Early Alzheimer’s Detection

Table of Contents

A new blood test offers a less invasive way to detect signs of Alzheimer’s disease, potentially years before symptoms appear. Researchers have developed a biomarker test using dried blood spot samples, offering a simpler choice to current methods like spinal taps or expensive brain scans.

How the Test Works

The test analyzes blood samples for specific biomarkers – measurable indicators of a disease – related to Alzheimer’s pathology. Instead of requiring a large blood draw processed in a lab, this new method uses a small blood sample collected on a special card that dries quickly. This makes the test easier to administer and more accessible.

Why Early Detection Matters

Early detection of alzheimer’s is crucial for several reasons. It allows individuals and their families more time to plan for the future, participate in clinical trials, and potentially benefit from therapies designed to slow the disease’s progression.Currently, many people are diagnosed only after meaningful cognitive decline has already occurred.

Benefits of a Dried Blood Spot Test

  • Minimally Invasive: A simple blood sample is all that’s needed, avoiding more complex and uncomfortable procedures.
  • Accessibility: Dried blood spot tests can be easily collected and shipped, making them suitable for wider use, including in remote areas.
  • Cost-Effective: The test is expected to be less expensive than current diagnostic methods, potentially making it more available to a larger population.

What This Means for the Future

While this test is still under development, the initial results are promising. Researchers believe it could become a valuable tool for identifying individuals at risk of Alzheimer’s, allowing for earlier intervention and improved patient care.Further studies are needed to confirm the test’s accuracy and reliability in diverse populations.

Source

Huber, H. et al. A minimally invasive dried blood spot biomarker test for the detection of alzheimer’s disease pathology. Nature Medicine.https://doi.org/10.1038/s41591-025-04080-0 (2026).

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”